Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Subramanian

Showing results (141-150 of 183) with videos related to

Pageof 19
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 19, 2014
Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosisJacqueline G O'Leary, K Rajender Reddy, Florence Wong, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 22, 2024
An international, multicenter, survey-based analysis of practice and management of acute liver failureAhmet Gurakar, Isabel Conde Amiel, N Begum Ozturk, et al.
Journal of Viral Hepatitis|June 1, 2018
Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatmentK Agarwal, S H Ahn, M Elkhashab, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failuresJasmohan S Bajaj, Jacqueline G O'Leary, K Rajender Reddy, et al.
Hepatology (Baltimore, Md.)|October 29, 2017
Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemiaR Todd Stravitz, Michelle Gottfried, Valerie Durkalski, et al.
Critical Care Medicine|July 14, 2021
Use of the Molecular Adsorbent Recirculating System in Acute Liver Failure: Results of a Multicenter Propensity Score-Matched StudyAndrew J MacDonald, Ram M Subramanian, Jody C Olson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2022
Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis CohortJasmohan S Bajaj, Puneeta Tandon, Jacqueline G O'Leary, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2017
HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patientsD Wong, M Littlejohn, L Yuen, et al.
Hepatology (Baltimore, Md.)|October 25, 2016
A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosisPuneeta Tandon, K Rajender Reddy, Jacqueline G O'Leary, et al.
Hepatology (Baltimore, Md.)|December 23, 2015
The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosisJasmohan S Bajaj, K Rajender Reddy, Puneeta Tandon, et al.
Pageof 19

Showing results (141-150 of 183) with videos related to

Sort By:
Pageof 19
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 19, 2014
Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosisJacqueline G O'Leary, K Rajender Reddy, Florence Wong, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 22, 2024
An international, multicenter, survey-based analysis of practice and management of acute liver failureAhmet Gurakar, Isabel Conde Amiel, N Begum Ozturk, et al.
Journal of Viral Hepatitis|June 1, 2018
Safety and efficacy of vesatolimod (GS-9620) in patients with chronic hepatitis B who are not currently on antiviral treatmentK Agarwal, S H Ahn, M Elkhashab, et al.
Hepatology (Baltimore, Md.)|March 29, 2014
Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failuresJasmohan S Bajaj, Jacqueline G O'Leary, K Rajender Reddy, et al.
Hepatology (Baltimore, Md.)|October 29, 2017
Safety, tolerability, and pharmacokinetics of l-ornithine phenylacetate in patients with acute liver injury/failure and hyperammonemiaR Todd Stravitz, Michelle Gottfried, Valerie Durkalski, et al.
Critical Care Medicine|July 14, 2021
Use of the Molecular Adsorbent Recirculating System in Acute Liver Failure: Results of a Multicenter Propensity Score-Matched StudyAndrew J MacDonald, Ram M Subramanian, Jody C Olson, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 18, 2022
Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis CohortJasmohan S Bajaj, Puneeta Tandon, Jacqueline G O'Leary, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2017
HBeAg levels at week 24 predict response to 8 years of tenofovir in HBeAg-positive chronic hepatitis B patientsD Wong, M Littlejohn, L Yuen, et al.
Hepatology (Baltimore, Md.)|October 25, 2016
A Karnofsky performance status-based score predicts death after hospital discharge in patients with cirrhosisPuneeta Tandon, K Rajender Reddy, Jacqueline G O'Leary, et al.
Hepatology (Baltimore, Md.)|December 23, 2015
The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosisJasmohan S Bajaj, K Rajender Reddy, Puneeta Tandon, et al.
Pageof 19